A technological platform to overcome tumor resistance to anticancer therapies

By leveraging Italian and Austrian excellence in genetics, clinics and biotechnology, p-care cross-border collaboration takes aim at cancer drug resistance and develops innovative strategies for resensitizing tumors to therapies and spurring the immune system to fight cancer.

Our goals

TO STUDY the mechanisms of antineoplastic drug resistance TO FOSTER synergies and cross-border networks of excellence TO TEST the efficacy against tumor resistance of existing drugs used to treat diseases other than cancer TO BOOST research capacity and infrastructures by sharing experiences and technologies TO EXPLORE personalized medicine approaches in order to recapitulate patient’s tumor microenvironment and immune response in lab



Reach us by

+39 040 375 8030
Università degli Studi di Trieste - DSV Via Weiss 2 - Pal. Q 34128 Trieste